litlas
Log inCreate account

Jonathan D. Licht

Active 1990–2025

135
Papers
27,080
Citations
87
h-index
131
i10-index

Citations

Citations per year for Jonathan D. Licht1966: 1 citations1991: 15 citations1992: 9 citations1993: 10 citations1994: 17 citations1995: 28 citations1996: 29 citations1997: 65 citations1998: 94 citations1999: 159 citations2000: 167 citations2001: 155 citations2002: 156 citations2003: 175 citations2004: 200 citations2005: 220 citations2006: 173 citations2007: 192 citations2008: 165 citations2009: 209 citations2010: 250 citations2011: 333 citations2012: 347 citations2013: 345 citations2014: 383 citations2015: 348 citations2016: 335 citations2017: 308 citations2018: 291 citations2019: 854 citations2020: 917 citations2021: 906 citations2022: 723 citations2023: 501 citations2024: 774 citations2025: 380 citations2026: 7 citations1967–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,402 citing papers, 33.8% of this breakdownChina: 1,528 citing papers, 11.8% of this breakdownGermany: 881 citing papers, 6.8% of this breakdownUnited Kingdom: 766 citing papers, 5.9% of this breakdownItaly: 537 citing papers, 4.1% of this breakdownCanada: 523 citing papers, 4% of this breakdownFrance: 499 citing papers, 3.8% of this breakdownJapan: 403 citing papers, 3.1% of this breakdownAustralia: 290 citing papers, 2.2% of this breakdownNetherlands: 288 citing papers, 2.2% of this breakdownSpain: 273 citing papers, 2.1% of this breakdownSwitzerland: 221 citing papers, 1.7% of this breakdown
0%33.8%Other 18.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology60.7%
  • Medicine28.9%
  • Immunology and Microbiology6.3%
  • Neuroscience1%
  • Agricultural and Biological Sciences1%
  • Engineering0.4%
  • Other1.7%

Topics

  • Epigenetics and DNA Methylation7%
  • Acute Myeloid Leukemia Research4.3%
  • Histone Deacetylase Inhibitors Research3.7%
  • Protein Degradation and Inhibitors3%
  • RNA modifications and cancer2.9%
  • MicroRNA in disease regulation2.8%
  • Other76.3%

Coauthors

All papers

Open in search
  1. Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling

    Authors: Laura A. Sena, Sha Li, Amit Jairaman, Murali Prakriya, Teresa Ezponda, David A. Hildeman, Chyung‐Ru Wang, Paul T. Schumacker, Jonathan D. Licht, Harris Perlman, Paul Bryce, Navdeep S. Chandel - Immunity 2013 cited by 1,300

  2. Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

    Authors: María E. Figueroa, Omar Abdel‐Wahab, Chao Lü, Patrick S. Ward, Jay Patel, Alan H. Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F. Fernández, Martin S. Tallman, Zhuoxin Sun, Kristy Wolniak, Justine Peeters, Wei Liu, Sung Choe, Valeria R. Fantin, Elisabeth Paietta, Bob Löwenberg, Jonathan D. Licht, Lucy A. Godley, Ruud Delwel, Peter J.M. Valk, Craig B. Thompson, Ross L. Levine, Ari Melnick - Cancer Cell 2010 cited by 2,737

  3. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

    Authors: Thomas Thum, Carina Gross, Jan Fiedler, Thomas Fischer, Stephan Kissler, Markus Bussen, Paolo Galuppo, Steffen Just, Wolfgang Rottbauer, Stefan Frantz, M. Castoldi, Jürgen Soutschek, Victor Koteliansky, Andreas Rosenwald, M. Albert Basson, Jonathan D. Licht, John T. R. Pena, Sara H. Rouhanifard, Martina U. Muckenthaler, Thomas Tuschl, Gail R. Martin, Johann Bauersachs, Stefan Engelhardt - Nature 2008 cited by 2,357

  4. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture

    Authors: Nevin Yusufova, Andreas Kloetgen, Matt Teater, Adewola Osunsade, Jeannie M. Camarillo, Christopher R. Chin, Ashley S. Doane, Bryan J. Venters, Stephanie Portillo‐Ledesma, Joseph Conway, Jude M. Phillip, Olivier Elemento, David W. Scott, Wendy Béguelin, Jonathan D. Licht, Neil L. Kelleher, Louis M. Staudt, Arthur I. Skoultchi, Michael‐Christopher Keogh, Effie Apostolou, Christopher E. Mason, Marcin Imieliński, Tamar Schlick, Yael David, Aristotelis Tsirigos, C. David Allis, Alexey A. Soshnev, Ethel Cesarman, Ari Melnick - Nature 2020 cited by 265

  5. EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

    Authors: Wendy Béguelin, Relja Popovic, Matt Teater, Yanwen Jiang, Karen Bunting, Monica W. Rosen, Hao Shen, Shao Ning Yang, Ling Wang, Teresa Ezponda, Eva Martínez-García, Haikuo Zhang, Yupeng Zheng, Sharad K. Verma, Michael T. McCabe, Heidi M. Ott, Glenn S. Van Aller, Ryan G. Kruger, Yan Liu, Charles F. McHugh, David W. Scott, Young Rock Chung, Neil L. Kelleher, Rita Shaknovich, Caretha L. Creasy, Randy D. Gascoyne, Kwok‐Kin Wong, Leandro Cerchietti, Ross L. Levine, Omar Abdel‐Wahab, Jonathan D. Licht, Olivier Elemento, Ari Melnick - Cancer Cell 2013 cited by 841

  6. Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator

    Authors: Jung Kim, Yongik Lee, Xiaodong Lü, Bing Song, Ka-wing Fong, Qi Cao, Jonathan D. Licht, Jonathan C. Zhao, Jindan Yu - Cell Reports 2018 cited by 310

  7. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

    Authors: Simon J. Hogg, Olga Motorna, Leonie A. Cluse, Timothy M. Johanson, Hannah D. Coughlan, Ramya Raviram, Robert M. Myers, Matteo Costacurta, Izabela Todorovski, Lizzy Pijpers, Stefan Bjelosevic, Tobias Williams, Shannon N. Huskins, Conor J. Kearney, Jennifer R. Devlin, Zheng Fan, Jafar S. Jabbari, Ben P. Martin, Mohamed Fareh, Madison J. Kelly, Daphné Dupéré-Richer, Jarrod J. Sandow, Breon Feran, Deborah A. Knight, Tiffany Khong, Andrew Spencer, Simon J. Harrison, Gareth P. Gregory, Vihandha O. Wickramasinghe, Andrew I. Webb, Phillippa C. Taberlay, Kenneth D. Bromberg, Albert Lai, Anthony T. Papenfuss, Gordon K. Smyth, Rhys S. Allan, Jonathan D. Licht, Dan A. Landau, Omar Abdel‐Wahab, Jake Shortt, Stephin J. Vervoort, Ricky W. Johnstone - Molecular Cell 2021 cited by 170

  8. Piperlongumine conjugates induce targeted protein degradation

    Authors: Jing Pei, Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan, Shuo Zhou, Nan Hua, Samuel G. Mackintosh, Xuan Zhang, Kari B. Basso, Manasi Kamat, Qingping Yang, Jonathan D. Licht, Guangrong Zheng, Daohong Zhou, Dongwen Lv - Cell chemical biology 2023 cited by 71

  9. Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins

    Authors: Ryosuke Shirasaki, Geoffrey M. Matthews, Sara Gandolfi, Ricardo De Matos Simoes, Dennis L. Buckley, Joseline Raja, Quinlan Sievers, Johanna B. Brüggenthies, Olga Dashevsky, Haley Poarch, Huihui Tang, Megan Bariteau, Michal Sheffer, Yiguo Hu, Sondra L. Downey-Kopyscinski, Paul J. Hengeveld, Brian Glassner, Eugen Dhimolea, Christopher J. Ott, Tinghu Zhang, Nicholas Kwiatkowski, Jacob P. Laubach, Robert Schlossman, Paul G. Richardson, Aedín C. Culhane, Richard W.J. Groen, Eric S. Fischer, Francisca Vázquez, Aviad Tsherniak, William C. Hahn, Joan Levy, Daniel Auclair, Jonathan D. Licht, Jonathan J. Keats, Lawrence Boise, Benjamin L. Ebert, James E. Bradner, Nathanael S. Gray, Constantine S. Mitsiades - Cell Reports 2021 cited by 115

  10. The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling

    Authors: Lucas B. Sullivan, Eva Martínez-García, Hien P. Nguyen, Andrew R. Mullen, Éric Dufour, Sunil Sudarshan, Jonathan D. Licht, Ralph J. DeBerardinis, Navdeep S. Chandel - Molecular Cell 2013 cited by 305

  11. Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2

    Authors: Ronan P. Hanley, David Y. Nie, John R. Tabor, Fengling Li, Amin Sobh, Chenxi Xu, Natalie K. Barker, David Dilworth, Taraneh Hajian, Elisa Gibson, Magdalena M. Szewczyk, Peter J. Brown, Dalia Baršytė-Lovejoy, Laura E. Herring, Gang Greg Wang, Jonathan D. Licht, Masoud Vedadi, C.H. Arrowsmith, Lindsey I. James - Journal of the American Chemical Society 2023 cited by 62

  12. Targeting Epigenetics in Cancer

    Authors: Richard L. Bennett, Jonathan D. Licht - The Annual Review of Pharmacology and Toxicology 2017 cited by 255

  13. Recruitment of FBXO22 for targeted degradation of NSD2

    Authors: Yan Nie, John R. Tabor, Jianping Li, Maria Kutera, Jonathan St‐Germain, Ronan P. Hanley, Esther Wolf, Ethan Paulаkonis, Tristan M. G. Kenney, Shili Duan, Suman Shrestha, Dominic D. G. Owens, Matthew E. R. Maitland, Ailing Pon, Magdalena M. Szewczyk, Anthony Joseph Lamberto, Michael Menes, Fengling Li, Linda Z. Penn, Dalia Baršytė-Lovejoy, Nicholas G. Brown, Anthony M. Barsotti, Andrew W. Stamford, Jon L. Collins, Derek J. Wilson, Brian Raught, Jonathan D. Licht, Lindsey I. James, C.H. Arrowsmith - Nature Chemical Biology 2024 cited by 56

  14. The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer

    Authors: Richard L. Bennett, Alok Swaroop, Catalina Troche, Jonathan D. Licht - Cold Spring Harbor Perspectives in Medicine 2017 cited by 218

  15. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer

    Authors: Damiano Fantini, Alexander P. Glaser, Kalen Rimar, Yiduo Wang, Matthew J. Schipma, Nobish Varghese, Alfred Rademaker, Amir Behdad, Aparna Yellapa, Yanni Yu, Christie C. Sze, Lu Wang, Zibo Zhao, Susan E. Crawford, Deqing Hu, Jonathan D. Licht, Clayton K. Collings, Elizabeth T. Bartom, Dan Theodorescu, Ali Shilatifard, Joshua J. Meeks - Oncogene 2018 cited by 197

  16. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

    Authors: Marco Tartaglia, Charlotte M. Niemeyer, Alessandra Fragale, Xiaoling Song, Jochen Buechner, Andreas Jung, Karel Hählen, Henrik Hasle, Jonathan D. Licht, Bruce D. Gelb - Nature Genetics 2003 cited by 1,039

  17. Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation

    Authors: Relja Popovic, Eva Martínez-García, Ευγενία Γιαννοπούλου, Quanwei Zhang, Qingyang Zhang, Teresa Ezponda, Mrinal Y. Shah, Yupeng Zheng, Christine Will, Eliza C. Small, Youjia Hua, Marinka Bulic, Yanwen Jiang, Matteo Carrara, Raffaele Calogero, William L. Kath, Neil L. Kelleher, Ji-Ping Wang, Olivier Elemento, Jonathan D. Licht - PLoS Genetics 2014 cited by 239

  18. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

    Authors: Ricardo De Matos Simoes, Ryosuke Shirasaki, Sondra L. Downey-Kopyscinski, Geoffrey M. Matthews, Benjamin G. Barwick, Vikas A. Gupta, Daphné Dupéré-Richer, Shizuka Yamano, Yiguo Hu, Michal Sheffer, Eugen Dhimolea, Olga Dashevsky, Sara Gandolfi, Kazuya Ishiguro, Robin M. Meyers, Jordan Bryan, Neekesh V. Dharia, Paul J. Hengeveld, Johanna B. Brüggenthies, Huihui Tang, Andrew J. Aguirre, Quinlan Sievers, Benjamin L. Ebert, Brian Glassner, Christopher J. Ott, James E. Bradner, Nicholas Kwiatkowski, Daniel Auclair, Joan Levy, Jonathan J. Keats, Richard W.J. Groen, Nathanael S. Gray, Aedín C. Culhane, James M. McFarland, Joshua M. Dempster, Jonathan D. Licht, Lawrence Boise, William C. Hahn, Francisca Vázquez, Aviad Tsherniak, Constantine S. Mitsiades - Nature Cancer 2023 cited by 40

  19. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells

    Authors: Eva Martínez-García, Relja Popovic, Dong Joon Min, Steve M. M. Sweet, Paul M. Thomas, Leonid Zamdborg, Aaron Heffner, Christine Will, Laurence Lamy, Louis M. Staudt, David Levens, Neil L. Kelleher, Jonathan D. Licht - Blood 2010 cited by 357

  20. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer

    Authors: Teresa Ezponda, Relja Popovic, Maitri Shah, Eva Martínez-García, Yupeng Zheng, D-J Min, Christine Will, Antonino Neri, Neil L. Kelleher, Jian Yu, Jonathan D. Licht - Oncogene 2012 cited by 159

  21. Histone mutations in cancer

    Authors: Kimberly N. Espinoza Pereira, Jixiu Shan, Jonathan D. Licht, Richard L. Bennett - Biochemical Society Transactions 2023 cited by 34

  22. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver

    Authors: Richard L. Bennett, Aditya Bele, Eliza C. Small, Christine Will, Behnam Nabet, Jon A. Oyer, Xiaoxiao Huang, Rajarshi P. Ghosh, Adrian T. Grzybowski, Tao Yu, Qiao Zhang, Alberto Riva, Tanmay P. Lele, George C. Schatz, Neil L. Kelleher, Alexander J. Ruthenburg, Jan Liphardt, Jonathan D. Licht - Cancer Discovery 2019 cited by 105

  23. Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins

    Authors: Lu Li, Peike Sheng, Tianqi Li, Christopher J. Fields, Nicholas M. Hiers, Yuzhi Wang, Jianping Li, Casey M. Guardia, Jonathan D. Licht, Mingyi Xie - Genes & Development 2021 cited by 60

  24. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

    Authors: Teresa Ezponda, Daphné Dupéré-Richer, Christine Will, Eliza C. Small, Nobish Varghese, Tej Patel, Behnam Nabet, Relja Popovic, Jon A. Oyer, Marinka Bulic, Yupeng Zheng, Xiaoxiao Huang, Mrinal Y. Shah, Sayantan Maji, Alberto Riva, Manuela Occhionorelli, Giovanni Tonon, Neil L. Kelleher, Jonathan J. Keats, Jonathan D. Licht - Cell Reports 2017 cited by 135